Trial Medpath
Published November 19, 2026
Optimi Health Maps 2027 Psychedelic Pipeline: Psilocybin Phase 2b in Severe MDD ...
Read the full story at Trial Medpath
has laid out a 2027 clinical agenda centered on two late-stage psychedelic programs: a redesigned Phase 2b trial of its naturally derived psilocybin.
Surfaced by this Google Alert
- MDMA